Target intelligence / Profile preview

Bacterial DNA-directed RNA polymerase switch-region (RNAP switch-region)

Target
RNAP switch-region
Molecular classification
Enzyme, Transferase, DNA-directed RNA polymerase
01

Overview

The bacterial DNA-directed RNA polymerase (RNAP) switch-region is a critical regulatory site located at the base of the clamp domain of the enzyme. This region acts as a molecular hinge, allowing the clamp to open and close to facilitate the entry of promoter DNA into the active site cleft (Belogurov et al., 2009, Nature). Drugs targeting this pocket, such as the alpha-pyrone antibiotics myxopyronin and corallopyronin, bind to the switch region and lock the clamp in a specific conformation, effectively preventing the formation of a functional transcription initiation complex (Mukhopadhyay et al., 2008, Cell). Because this site is highly conserved across diverse bacterial species but structurally distinct from eukaryotic RNA polymerases, it serves as an attractive target for the development of broad-spectrum antibacterial agents (Srivastava et al., 2011, Curr Opin Microbiol). Targeting the switch region is particularly valuable in clinical settings as it does not show cross-resistance with rifampicin, which binds to a different site on the RNAP, making it a viable option for treating multi-drug resistant infections like tuberculosis (Mayer et al., 2022, Angewandte Chemie).

Other names
Switch-region pocketClamp-hinge pocketRNAP switch regionMyxopyronin binding siteSwitch-region/clamp-hinge pocket
02

Mechanism of action

Inhibition of transcription initiation by binding to the switch region, which acts as a hinge for the RNAP clamp, thereby preventing the conformational changes (clamp closure) necessary for DNA template binding and promoter melting.

03

Biological functions

TranscriptionRNA synthesisDNA bindingProtein conformational changeTranscription initiation
04

Disease associations

Bacterial infectionTuberculosisMethicillin-resistant Staphylococcus aureus (MRSA) infection
05

Safety considerations

Development of resistance via target mutations (e.g., in rpoB or rpoC genes)Potential off-target effects if eukaryotic selectivity is lostPoor pharmacological properties of natural product leads
06

Interacting drugs

Myxopyronin

3 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial loadRNA transcript levels

Beyond the preview

Go deeper on Bacterial DNA-directed RNA polymerase switch-region (RNAP switch-region).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA-directed RNA polymerase switch-region (RNAP switch-region).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call